Printer Friendly

AVECOR CARDIOVASCULAR REPORTS SECOND QUARTER RESULTS

 AVECOR CARDIOVASCULAR REPORTS SECOND QUARTER RESULTS
 MINNEAPOLIS, Aug. 6 /PRNewswire/ -- AVECOR Cardiovascular Inc.


(NASDAQ: AVEC) today reported net income of $11,658, or less than 1 cent per share, for the three months ended June 30, 1992, compared with a loss of $5,859, also less than 1 cent per share, in the year-ago quarter. Net sales were $2,981,642, compared with sales of $569,425 in the 1991 quarter when the company had only three weeks of operations.
 For the first six months, the company reported net income of $47,983, or 1 cent per share, on net sales of $5,749,713. For the first half of 1991, the company had a loss of $5,859, or less than 1 cent per share, on net sales of $569,425.
 "All of our existing products continued to perform well," said Anthony Badolato, president and chief executive officer. "Unit sales were about in line with the first quarter, and a 7 percent price increase in certain product lines contributed to dollar sales growth.
 "We continue to expand our research and development efforts, with second quarter spending up 55 percent over the first quarter. As this effort accelerates, we continue to expect losses for this year and next."
 AVECOR Cardiovascular Inc., headquartered in Minneapolis, develops, manufactures and markets specialty disposable medical devices for heart/lung bypass surgery and long-term respiratory support. The company's current products include membrane oxygenators, cardiotomy reservoirs and cardioplegia systems.
 AVECOR CARDIOVASCULAR INC.
 3 months ended June 30 6 months ended June 30
 1992 1991 1992 1991
 Net sales $2,981,642 $ 569,425 $5,749,713 $ 569,425
 Net income (loss) 11,658 (5,859) 47,983 (5,859)
 Earnings (loss) per
 share $.00 $(.00) $.01 $(.00)
 Common and common
 equivalent shares
 outstanding 6,197,848 1,922,959 4,760,064 1,922,959
 -0- 8/6/92
 /CONTACT: Curt Swenson of Swenson Falker Eilertsen, 612-371-0000 or Norm McGibbon of AVECOR Cardiovascular, 612-559-9504/
 (AVEC) CO: AVECOR Cardiovascular, Inc. ST: Minnesota IN: MTC SU: ERN


KH -- MN005 -- 7583 08/06/92 12:08 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 6, 1992
Words:348
Previous Article:BOEING 737 TO SURPASS 3,000-ORDER MARK
Next Article:F.W. WOOLWORTH CO. TO ACQUIRE 89 JOAN BARI STORES
Topics:


Related Articles
AVECOR CARDIOVASCULAR REPORTS FIRST QUARTER PROFIT
AVECOR CARDIOVASCULAR REPORTS SECOND QUARTER RESULTS
AVECOR CARDIOVASCULAR REPORTS THIRD QUARTER RESULTS
AVECOR CARDIOVASCULAR REPORTS FOURTH QUARTER, YEAR-END RESULTS
AVECOR CARDIOVASCULAR REPORTS FIRST QUARTER RESULTS AND ANNOUNCES SUBMISSION OF NEW OXYGENATOR TO FDA
AVECOR CARDIOVASCULAR REPORTS SECOND QUARTER LOSS
AVECOR CARDIOVASCULAR REPORTS 1993 FOURTH QUARTER, YEAR-END RESULTS
AVECOR CARDIOVASCULAR REPORTS LOSS NARROWED IN 1ST QUARTER OF 1994
AVECOR CARDIOVASCULAR REPORTS HIGHER SALES, SMALLER LOSS FOR 2ND QUARTER OF 1994
AVECOR Cardiovascular Reports 2nd Quarter Earnings

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters